Importance of CD23 for collagen-induced arthritis: Delayed onset and reduced severity in CD23-deficient mice

Journal of Immunology

Volumn 162, Issue 7, 1999, Pages 4266-4270

  Kleinau, Sandra ^a   Martinsson, Pernilla ^a   Gustavsson, Susanne ^a   Heyman, Birgitta ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CD23 ANTIGEN;

ANIMAL EXPERIMENT; ARTHRITIS; ARTICLE; DISEASE SEVERITY; FEMALE; IMMUNE RESPONSE; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RECEPTOR AFFINITY; RHEUMATOID ARTHRITIS;

ANIMALS; ARTHRITIS, RHEUMATOID; COLLAGEN; DISEASE MODELS, ANIMAL; FEMALE; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, MUTANT STRAINS; RECEPTORS, IGE; SPECIES SPECIFICITY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033120993     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Courtenay, J. S., M. J. Dallman, A. D. Dayan, A. Martin, and B. Mosedale. 1980. Immunisation against heterologous type II collagen induces arthritis in mice. Nature 283:666.
2. Wooley, P. H., H. S. Luthra, J. M. Stuart, and C. S. David. 1981. Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates. J. Exp. Med. 154:688.
3. Watson, W. C., and A. S. Townes. 1985. Genetic susceptibility to marine collagen II autoimmune arthritis: proposed relationship to the IgG2 autoantibody subclass response, complement C5, major histocompatibility complex (MHC) and non-MHC loci. J. Exp. Med. 162:1878.
4. Mauri, C., R. O. Williams, M. Walmsey, and M. Feldman. 1996. Relationship between Th1/Th2 cytokine patterns and the arthritogenic response in collagen-induced arthritis. Eur. J. Immunol. 26:1511.
5. Seki, N., Y. Sudo, T. Yoshioka, S. Sugihara, T. Fujitsu, S. Sakuma, T. Ogawa, T. Hamaoka, H. Senoh, and H. Fujiwara. 1988. Type II collagen-induced murine arthritis. I. Induction and perpetuation of arthritis require synergy between humoral and cell-mediated immunity. J. Immunol. 140:1477.
6. Horn, J. T., L. D. Butler, P. E. Riedl, and A. M. Bendele. 1988 The progression of the inflammation in established collagen-induced arthritis can be altered by treatments with immunological or pharmacological agents which inhibit T cell activities. Eur. J. Immunol. 18:881.
7. Van den Berg, W. B., L. A. B. Joosten, M. Helsen, and F. A. J. Van de Loo. 1994. Amelioration of established murine collagen-induced arthritis with anti-IL-1 treatment. Clin. Exp. Immunol. 95:237.
8. Thorbecke, G. J., R. Shah, C. H. Leu, A. P. Kuruvilla, A. M. Hardison, and M. A. Palladino. 1992. Involvement of endogenous tumor necrosis factor α and transforming growth factor β during induction of collagen type II arthritis in mice. Proc. Natl. Acad. Sci. USA 89:7375.
9. Williams, R. O., M. Feldmann, and R. N. Maini. 1992. Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc. Natl. Acad. Sci. USA 89:9784.
10. Rao, M., W. T. Lee, and D. H. Conrad. 1987. Characterization of a monoclonal antibody directed against the murine B lymphocyte receptor for IgE. J. Immunol. 138:1845.
11. Maeda, K., G. F. Burton, D. A. Pargett, D. H. Conrad, T. F. Huff, A. Masuda, A. K. Szakal, and J. G. Tew. 1992. Murine follicular dendritic cells and low affinity receptors for IgE (Fc∈RII). J. Immunol. 148:2340.
12. Sandor, M., G. A. Cook, R. E. Sacco, R. Mathew, A. Ibraghimov, J. V. Weinstock, and R. G. Lynch. 1992. TCR induced expression of Fc receptors on murine T cell subsets in vitro and in vivo. Immunobiology 185:268.
13. Gordon, J. 1991. CD23: a novel multifunctional regulator of the immune system that binds IgE. In Monographs in Allergy, L. A. Hanson and F. Shakib, eds. Karger, Basel, p. 29.
14. Kumagai, S., H. Ishida, K. Iwai, T. Tsubata, H. Umehara, S. Ozaki, T. Suginoshita, S. Araya, and H. Imura. 1989. Possible different mechanisms of B cell activation in systemic lupus erythematosus and rheumatoid arthritis: opposite expression of low-affinity receptors for IgE (CD23) on their peripheral B cells. Clin. Exp. Immunol. 78:348.
15. Chomarat, P., J. Briolay, J. Banchereau, and P. Miossec. 1993. Increased production of soluble CD23 in rheumatoid arthritis, and its regulation by interleukin-4. Arthritis Rheum. 36:234.
16. Bansal, A. S., W. Ollier, M. N. Marsh, R. S. H. Pumphrey, and P. B. Wilson. 1993. Variations in serum sCD23 in conditions with either enhanced humoral or cell-mediated immunity. Immunology 79:285.
17. Rezonzew, R., and M. M. Newkirk. 1994. Impaired release of sCD23 by activated B-cells from RA patients. Clin. Immunol. Immunopathol. 71:156.
18. Roussou, E., J. Gordon, and C. Sykes. 1991. Soluble CD23 expression in patients with rheumatoid arthritis. Br. J. Rheumatol. 30(suppl. 2):110.
19. Bansal, A. S., A. J. Macgregor, R. S. H. Pumphrey, A. J. Silman, W. E. R. Ollier, and P. B. Wilson. 1994. Increased levels of sCD23 in rheumatoid arthritis are related to disease status. Clin: Exp. Rheumatol. 12:281.
20. Bansal, A., T. Roberts, E. Hay, R. Kay, R. Pumphrey, and P. Wilson. 1992. Soluble CD23 levels are elevated in serum of patients with primary Sjögren's syndrome and systemic lupus erythematosus. Clin. Exp. Immunol. 89:452.
21. Plater-Zyberk, C., and J.-Y. Bonnefoy. 1995. Marked amelioration of established collagen-induced arthritis by treatment with antibodies to CD 23 in vivo. Nat. Med. 1:781.
22. Fujiwara, H., H. Kikutani, S. Suematsu, T. Naka, K. Yoshida, T. Tanaka, N. Suemura, N. Matsumoto, S. Kojima, T. Kishimoto, and N. Yoshida. 1994. The absence of IgE antibody-mediated augmentation of immune responses in CD23-deficient mice. Proc. Natl. Acad. Sci. USA 86:7556.
23. Millet, E. J. 1972. Structural studies on cartilage collagen employing limited cleavage and solubilization with pepsin. Biochemistry 11:4903.
24. Müssener, Å., L. Klareskog, J. C. Lorentzen, and S. Kleinau. 1995. TNF-α dominates cytokine mRNA expression in lymphoid tissue of rats developing collagen-and oil-induced arthritis. Scand. J. Immunol. 42:128.
25. Lecoanet-Henchoz, S., J.-F. Gauchat, J.-P. Aubry, P. Graber, P. Life, N. Paul-Eugene, B. Ferrua, A. L. Corbi, B. Dugas, C. Plater-Zyberk, and J.-Y. Bonnefoy. 1995. CD23 regulates monocyte activation through a novel interaction with adhesion molecules CD11b-CD18 and CD11c-CD18. Immunity 3:119.
26. Hashimoto, S., K. Koh, Y. Tomita, E. Amemiya, S. Sawada, J. Yodoi, and T. Horie. 1995. TNF-α regulates IL-4 induced Fc∈RII/CD23 gene expression and soluble Fc∈RII release by human monocytes. Int. Immunol. 7:705.
27. Heyman, B., L. Tianmin, and S. Gustavsson. 1993. In vivo enhancement of the specific antibody response via the low-affinity receptor for IgE. Eur. J. Immunol. 23:1739.
28. Kehry, M. R., and L. C. Yamashita. 1989. Low-affinity IgE receptor (CD23) function on mouse B cells: role in IgE-dependent antigen focusing. Proc. Natl. Acad. Sci. USA 86:7556.
29. Pirron, U., T. Schlunck, J. C. Prinz, and E. P. Rieber. 1990. IgE-dependent antigen focusing by human B lymphocytes is mediated by low-affinity receptor for IgE. Eur. J. Immunol. 20:1547.
30. van der Heijden, F. L., R. J. J. van Neerven, M. van Katwijk, J. D. Bos, and M. L. Kaspenberg. 1993. Serum-IgE-facilitated allergen presentation in atopic disease. J. Immunol. 150:1.
31. Lecoanet-Henchoz, S., C. Plater-Zyberk, P. Graber, D. Gretener, J.-P. Aubry, D. H. Conrad, and J.-Y. Bonnefoy. 1997. Mouse CD23 regulates monocyte activation through an interaction with the adhesion molecule CD11b/CD18. Eur. J. Immunol. 27:2290.
32. Piguet, P. F., G. E. Grau, C. Vesin, H. Loetscher, R. Gentz, and W. Lesslauer. 1992. Evolution of collagen arthritis in mice is arrested by treatment with anti-tumor necrosis factor (TNF) antibody or recombinant soluble TNF receptor. Immunology 77:510.